An announcement from Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) is now available.
Shanghai Pharmaceuticals Holding Co., Ltd. announced that its subsidiary, Shanghai Sine United Medicinal Herbs Co., Ltd., received an administrative penalty from the Shanghai Municipal Administration for Market Regulation for violating anti-monopoly laws. The penalty includes a fine and forfeiture of illegal income, but the financial impact on the parent company is limited due to the subsidiary’s small contribution to overall revenue. The company has taken steps to enhance compliance and prevent future monopolistic behavior, reflecting its commitment to fair market practices and sustainable development.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. is a major player in the pharmaceutical industry in China, focusing on the production and distribution of medicinal products. It operates through a network of subsidiaries, with a market focus on both domestic and international pharmaceutical markets.
YTD Price Performance: -3.99%
Average Trading Volume: 29,934
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $7.91B
Find detailed analytics on 2607 stock on TipRanks’ Stock Analysis page.